These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents. Byers VS; Pimm MV; Pawluczyk IZ; Lee HM; Scannon PJ; Baldwin RW Cancer Res; 1987 Oct; 47(20):5277-83. PubMed ID: 3498532 [TBL] [Abstract][Full Text] [Related]
3. [Preparation of SOKT1-RTA immunotoxin and its specific cytotoxic effect on human T lymphocytes]. Zhong W; Dai B Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):240-4. PubMed ID: 1748404 [TBL] [Abstract][Full Text] [Related]
4. A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin. Castelletti D; Fracasso G; Righetti S; Tridente G; Schnell R; Engert A; Colombatti M Clin Exp Immunol; 2004 May; 136(2):365-72. PubMed ID: 15086403 [TBL] [Abstract][Full Text] [Related]
5. Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients. Durrant LG; Byers VS; Scannon PJ; Rodvien R; Grant K; Robins RA; Marksman RA; Baldwin RW Clin Exp Immunol; 1989 Feb; 75(2):258-64. PubMed ID: 2784738 [TBL] [Abstract][Full Text] [Related]
6. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents. Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572 [TBL] [Abstract][Full Text] [Related]
7. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells. Zhou XX; Ji F; Zhao JL; Cheng LF; Xu CF J Gastroenterol Hepatol; 2010 Jul; 25(7):1266-75. PubMed ID: 20594254 [TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821 [TBL] [Abstract][Full Text] [Related]
10. Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity. Woo BH; Lee JT; Lee KC Arch Pharm Res; 1994 Dec; 17(6):452-7. PubMed ID: 10319157 [TBL] [Abstract][Full Text] [Related]
11. Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MEL. Mischak RP; Foxall C; Rosendorf LL; Knebel K; Scannon PJ; Spitler LE Mol Biother; 1990 Jun; 2(2):104-9. PubMed ID: 2363853 [TBL] [Abstract][Full Text] [Related]
12. Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial. Oratz R; Speyer JL; Wernz JC; Hochster H; Meyers M; Mischak R; Spitler LE J Biol Response Mod; 1990 Aug; 9(4):345-54. PubMed ID: 2395000 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates. Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715 [TBL] [Abstract][Full Text] [Related]
14. [Influences of an anti-pan-T cell ricin A-chain immunotoxin on generation of human immunocompetent T cells and hematopoietic progenitor cells]. Zhong W; Dai B Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):344-7. PubMed ID: 1839987 [TBL] [Abstract][Full Text] [Related]
15. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer. Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828 [TBL] [Abstract][Full Text] [Related]
16. Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanoma. Hertler AA; Spitler LE; Frankel AE Cancer Drug Deliv; 1987; 4(4):245-53. PubMed ID: 3502618 [TBL] [Abstract][Full Text] [Related]
17. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas. Kornfeld SB; Leonard JE; Mullen MD; Taetle R Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines. Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523 [TBL] [Abstract][Full Text] [Related]
20. Effect of cyclophosphamide on the immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats. Harkonen S; Mischak R; Lopez H; Stoudemire J Cancer Drug Deliv; 1987; 4(3):151-7. PubMed ID: 3502453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]